Key Highlights

INR 145,848 mn

Net Sales

INR 14,324 mn

Investement in R&D

886

Patents Filed

7 State-of-the-Art

Research Facilities

15 World-Class

Manufacturing Facilities

12% Energy needs

met by Renewable Sources

Ranks #3

in the USA by Prescriptions

Ranks #6

in the Indian Pharma Market

Our Value
Creation Model

Our Value Creation Model

Financial
Capital

Read More

Manufacturing
Capital

Read More

Intellectual
Capital

Read More

Human
Capital

Read More

Social and
Relationship
Capital

Read More

Natural
Capital

Read More
Download Reports

INTEGRATED REPORT
2021 - 2022

Download Download Reports